| Tillotts Pharma AG - Yaldigo 800 mg, magensaftesistente Tablette | | 53108 | | 02 | | Yaldigo 800 mg | | magensaftesistente Tablette | | A07EC02 | | Mesalazin | | 25.09.2002 | | |
| | Composition | | mesalazinum 800 mg, lactosum monohydricum 153 mg, carboxymethylamylum natricum A corresp. natrium 1.537 mg, magnesii stearas, talcum, povidonum K 25, Überzug: acidi methacrylici et methylis methacrylatis polymerisatum 1:2, talcum, triethylis citras, macrogolum 6000, E 172, pro compresso obducto. | | Packungsbestandteile | | magensaftesistente Tablette | | | | Principe actif | Concentr. |
|---|
| Mesalazine | 800 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Acidi Methacrylici | | Überzug | | Carboxymethylamylum Natricum A | | | | E 172 | | color. | | Lactose Monohydrate | 153 mg | | | Macrogol | 6000 | | | Magnesii Stearas | | | | Methylis Methacrylatis Polymerisatum | | | | Povidonum K | 25 | | | Pro Compresso Obducto | | | | Talcum | | | | Triethylis Citras | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 005 | 90 | | | B | | Non | | 007 | 30 | | | B | | Non |
|
|
